Custom Search
 


(A) Potential tumor boundaries marked with blue boundaries and (B) automatically extracted vessel regions with blue boundaries in grayscale.
 
 
Niramai contactless breast cancer screeening, now at Apollo hospitals

Leading international oncology journal, publishes  Niramai findings
Bangalore, October 11 2020: Niramai Health Analytix, the Indian AI-based  contactless breast cancer screening company has tied-up with Apollo Clinic, India’s leading multi-specialty clinics to offer contact-less, privacy-sensitive, breast cancer screening services to customers.
The screening services will be initially available at all Apollo Clinic clinics across Bengaluru, Hyderabad, Chennai, and Pune and will be ramped up pan-India in due course. 
Customers will now be able to get themselves screened for their annual preventive breast screening and regular breast health check-ups. The test is appropriate for women 18 years and above and is privacy aware, non-invasive, radiation free and can detect the minutest of lumps or abnormalities. Customers can avail the screening service either at the various Apollo Clinic locations or can even book home-screening services through their nearest Apollo Clinic centre.   
Niramai’s proprietary solution ‘Thermalytix’ uses a high resolution thermal sensing device and a cloud hosted analytics solution for analyzing thermal images using big data analytics, artificial intelligence and machine learning for reliable, early and accurate breast cancer screening. This solution has led to 9 US granted patents and several prestigious awards.
-------------------------------------------------------------------------------------------------------------------------------------
NIRAMAI's systematic study evaluating the clinical efficacy of Thermalytix solution is
now published in the most reputed ASCO Journal of Clinical Oncology (JCO GO).

The report evaluates the sensitivity and specificity of Thermalytix, an artificial intelligence-based
computer-aided diagnostics (CADx) engine, to detect breast malignancy by comparing the CADx
output with the final diagnosis derived using standard screening modalities.
Link: to full text of the paper here
---------------------------------------------------------------------------------------------------------------------------------------
Says Dr. Geetha Manjunath, Founder & CEO, Niramai: “Our mission is to create a universal cancer screening solution to enable early detection of abnormalities even before a symptom appears, which dramatically reduces treatment cost, increases treatment effectiveness and most importantly provides a healthy life to people. We are excited to partner with Apollo Clinic to take our clinically proven Thermalytix screening service to many more women in India and save lives.”
Adds Anand Wasker, Chief Operating Officer, Apollo Clinic: “We provide all Primary Healthcare services under one roof via Apollo Clinic format and are committed to offering world-class healthcare services to our customers. We are delighted to partner with an innovative company like Niramai to offer early stage breast screening that will benefit our customers.” 
Niramai Health Analytix is a deep-tech company with expertise in thermal imaging and AI. Their innovative AI drive diagnostic engine called Thermalytix enables a radiation-free, non-invasive, non-touch, breast cancer screening solution for hospitals and diagnostic centers. NIRAMAI has recently also developed a new solution called FeverTest for Automated COVID Screening leveraging its expertise in thermal imaging and AI.
The innovative machine learning techniques used in Niramai’s solution have led to 9 US granted patents. Niramai has won many awards including the Gold prize in Hack Osaka 2019, Aegis Graham Bell Award, Frost and Sullivan Award and has been part of accelerators such as Google Launchpad, Philips Healthworks, Nvidia Inception, BIRAC Winner, Elevate 100 and others. Niramai is the only Indian company listed on the 2019 Top AI 100 startups in the world announced by CB Insights.

Bangalore, October 11 2020: Niramai Health Analytix, the Indian AI-based  contactless breast cancer screening company has tied-up with Apollo Clinic, India’s leading multi-specialty clinics to offer contact-less, privacy-sensitive, breast cancer screening services to customers. The screening services will be initially available at all Apollo Clinic clinics across Bengaluru, Hyderabad, Chennai, and Pune and will be ramped up pan-India in due course. 

Customers will now be able to get themselves screened for their annual preventive breast screening and regular breast health check-ups. The test is appropriate for women 18 years and above and is privacy aware, non-invasive, radiation free and can detect the minutest of lumps or abnormalities. Customers can avail the screening service either at the various Apollo Clinic locations or can even book home-screening services through their nearest Apollo Clinic centre.   

Niramai’s proprietary solution ‘Thermalytix’ uses a high resolution thermal sensing device and a cloud hosted analytics solution for analyzing thermal images using big data analytics, artificial intelligence and machine learning for reliable, early and accurate breast cancer screening. This solution has led to 9 US granted patents and several prestigious awards.
-----------------------------------------------------------------------------------------------------------------------------
NIRAMAI's systematic study evaluating the clinical efficacy of Thermalytix solution is now published in the most reputed ASCO Journal of Clinical Oncology (JCO GO). The report evaluates the sensitivity and specificity of Thermalytix, an artificial intelligence-based computer-aided diagnostics (CADx) engine, to detect breast malignancy by comparing the CADx output with the final diagnosis derived using standard screening modalities. Link: to full text of the paper here

 

Says Dr. Geetha Manjunath, Founder & CEO, Niramai: “Our mission is to create a universal cancer screening solution to enable early detection of abnormalities even before a symptom appears, which dramatically reduces treatment cost, increases treatment effectiveness and most importantly provides a healthy life to people. We are excited to partner with Apollo Clinic to take our clinically proven Thermalytix screening service to many more women in India and save lives.”
Adds Anand Wasker, Chief Operating Officer, Apollo Clinic: “We provide all Primary Healthcare services under one roof via Apollo Clinic format and are committed to offering world-class healthcare services to our customers. We are delighted to partner with an innovative company like Niramai to offer early stage breast screening that will benefit our customers.” 

 

Niramai Health Analytix is a deep-tech company with expertise in thermal imaging and AI. Their innovative AI drive diagnostic engine called Thermalytix enables a radiation-free, non-invasive, non-touch, breast cancer screening solution for hospitals and diagnostic centers. NIRAMAI has recently also developed a new solution called FeverTest for Automated COVID Screening leveraging its expertise in thermal imaging and AI.

The innovative machine learning techniques used in Niramai’s solution have led to 9 US granted patents. Niramai has won many awards including the Gold prize in Hack Osaka 2019, Aegis Graham Bell Award, Frost and Sullivan Award and has been part of accelerators such as Google Launchpad, Philips Healthworks, Nvidia Inception, BIRAC Winner, Elevate 100 and others. Niramai is the only Indian company listed on the 2019 Top AI 100 startups in the world announced by CB Insights.